Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19

Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19

Background: New tools for the assessment and prediction of the severity of hospitalized COVID-19 patients can help direct limited resources to patients with the greatest need. Circulating levels of calprotectin (S100A8/S100A9) reflect inflammatory activity in multiple conditions, and have been descr...

Full description

Bibliographic Details
Main Authors: Gary L. Norman, Sherwin A. Navaz, Yogendra Kanthi, Roger Albesa, Michael Mahler, Jason S. Knight, Yu Zuo
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Diagnostics
Subjects:
calprotectin
serum
biomarker
COVID-19
SARS-CoV-2
severity
Online Access:https://www.mdpi.com/2075-4418/12/6/1324

Internet

https://www.mdpi.com/2075-4418/12/6/1324

Similar Items